News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
62,246 Results
Type
Article (1428)
Company Profile (14)
Press Release (60804)
Section
Business (29922)
Career Advice (50)
Deals (4516)
Drug Delivery (3)
Drug Development (6062)
Employer Resources (3)
FDA (1064)
Job Trends (1460)
News (39578)
Policy (2125)
Tag
2027 Biotech Bay Standard (1)
Academia (115)
Accelerated approval (1)
Adcomms (1)
Allergies (22)
Alliances (2078)
ALS (8)
Alzheimer's disease (129)
Antibody-drug conjugate (ADC) (45)
Approvals (1148)
Artificial intelligence (18)
Autoimmune disease (14)
Automation (3)
Bankruptcy (13)
Best Places to Work (1391)
BIOSECURE Act (1)
Biosimilars (6)
Biotechnology (7)
Bladder cancer (22)
Brain cancer (2)
Breast cancer (97)
Cancer (637)
Cardiovascular disease (51)
Career advice (49)
Career pathing (2)
CAR-T (25)
CDC (1)
Cell therapy (59)
Cervical cancer (3)
Clinical research (5902)
Collaboration (66)
Compensation (61)
Complete response letters (4)
COVID-19 (148)
CRISPR (6)
C-suite (23)
Cystic fibrosis (9)
Data (794)
Depression (11)
Diabetes (65)
Diagnostics (693)
Digital health (4)
Diversity, equity & inclusion (1)
Drug discovery (8)
Drug pricing (8)
Duchenne muscular dystrophy (6)
Earnings (28790)
Editorial (1)
Employer branding (1)
Employer resources (3)
Events (6049)
Executive appointments (23)
FDA (1564)
Fibrodysplasia Ossificans Progressiva (4)
Frontotemporal dementia (3)
Funding (60)
Gene editing (17)
Gene therapy (46)
GLP-1 (73)
Government (237)
Grass and pollen (1)
Guidances (259)
Healthcare (1940)
IgA nephropathy (7)
Immunology and inflammation (25)
Immuno-oncology (1)
Indications (17)
Infectious disease (165)
Inflammatory bowel disease (14)
Influenza (5)
Intellectual property (5)
Interviews (4)
IPO (3422)
IRA (2)
Job creations (153)
Job search strategy (45)
JPM (1)
Kidney cancer (2)
Labor market (2)
Layoffs (19)
Leadership (1)
Legal (408)
Liver cancer (7)
Lung cancer (106)
Lymphoma (119)
Machine learning (3)
Manufacturing (31)
MASH (21)
Medical device (1522)
Medtech (1527)
Mergers & acquisitions (1186)
Metabolic disorders (130)
Multiple sclerosis (15)
NASH (2)
Neurodegenerative disease (15)
Neuropsychiatric disorders (8)
Neuroscience (209)
NextGen: Class of 2026 (479)
Non-profit (250)
Obesity (43)
Opinion (5)
Ovarian cancer (12)
Pain (8)
Pancreatic cancer (23)
Parkinson's disease (19)
Patents (21)
Patient recruitment (23)
Peanut (9)
People (1663)
Pharmaceutical (4)
Pharmacy benefit managers (5)
Phase 1 (1307)
Phase 2 (2247)
Phase 3 (2739)
Pipeline (1411)
Policy (7)
Postmarket research (250)
Preclinical (330)
Press Release (1)
Prostate cancer (27)
Psychedelics (1)
Radiopharmaceuticals (24)
Rare diseases (80)
Real estate (220)
Recruiting (1)
Regulatory (1824)
Reports (7)
Research institute (131)
Resumes & cover letters (1)
Rett syndrome (1)
RNA editing (1)
RSV (6)
Schizophrenia (12)
Series A (5)
Series B (6)
Service/supplier (1)
Sickle cell disease (15)
Special edition (2)
Spinal muscular atrophy (8)
Startups (107)
Stomach cancer (1)
Supply chain (6)
Tariffs (2)
Vaccines (59)
Weight loss (28)
Women's health (7)
Worklife (1)
Date
Today (13)
Last 7 days (71)
Last 30 days (243)
Last 365 days (3886)
2026 (343)
2025 (3959)
2024 (4626)
2023 (5014)
2022 (5665)
2021 (6585)
2020 (5547)
2019 (4131)
2018 (3258)
2017 (2982)
2016 (2009)
2015 (3046)
2014 (1838)
2013 (1017)
2012 (1136)
2011 (1506)
2010 (1481)
Location
Africa (50)
Alabama (10)
Arizona (19)
Asia (3920)
Australia (356)
California (1386)
Canada (459)
China (126)
Colorado (81)
Connecticut (66)
Delaware (76)
Europe (8017)
Florida (204)
Georgia (54)
Idaho (6)
Illinois (76)
India (5)
Indiana (72)
Japan (74)
Kansas (7)
Kentucky (5)
Louisiana (9)
Maine (16)
Maryland (151)
Massachusetts (906)
Michigan (55)
Minnesota (74)
Missouri (11)
Montana (2)
Nebraska (1)
Nevada (12)
New Hampshire (9)
New Jersey (605)
New Mexico (1)
New York (379)
North Carolina (238)
Northern California (737)
Ohio (29)
Oregon (1)
Pennsylvania (300)
Rhode Island (1)
South America (78)
South Carolina (1)
Southern California (529)
Tennessee (17)
Texas (173)
United States (5195)
Utah (48)
Virginia (23)
Washington D.C. (17)
Washington State (153)
Wisconsin (16)
62,246 Results for "66".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MDCE CEO Expands Open-Market Position to 66,199,283 Shares After Previously Returning Nearly 2 Billion Shares to Treasury
February 20, 2026
·
3 min read
Press Releases
Attivare Therapeutics Awarded $6.6 Million Grant to Advance Durable Malaria Vaccine
December 15, 2025
·
2 min read
Press Releases
Lyric Bio, Inc. Closes $6.6 Million Seed Financing To Revolutionize Donor-Derived Therapeutics
December 3, 2025
·
3 min read
Press Releases
Ryoncil® Revenues Increase 66% in Second Quarter Post Launch
October 6, 2025
·
5 min read
Press Releases
U.S. Liver Cancer Diagnostics Market Size to Exceed USD 4.66 Billion by 2034
November 11, 2025
·
1 min read
Press Releases
Immunofoco Presents Phase I/IIa Data of IMC002 at ASCO GI 2026, Highlighting a Durable Complete Response Beyond One Year and a 66.7% ORR in Advanced GC/GEJ
January 13, 2026
·
5 min read
Press Releases
Hyperion DeFi Reports Third Quarter 2025 Financial Results with Record Net Income of $6.6 Million
November 14, 2025
·
31 min read
Press Releases
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to 66 employees
June 19, 2025
·
1 min read
Press Releases
Celldex Presents Results from Barzolvolimab Phase 2 Study in Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Demonstrating Sustained Efficacy and Favorable Safety Profile over 20 Week Placebo Controlled Treatment Period; Up to 66% of Patients with ColdU and 49% with SD Obtain Complete Response at Week 20
November 7, 2025
·
9 min read
Press Releases
Lenalidomide Drug Market to Reach USD 22.04 Bn by 2032 with A Growth Rate of 6.6% – Report by Coherent Market Insights
June 18, 2025
·
1 min read
1 of 6,225
Next
